Clinical trial

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

NCT00321009 · Corewell Health East, Other · Completed

Key facts

NCT number NCT00321009
Title LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
Official title A Prospective Randomized Trial Comparing Enoxaparin to Warfarin for the Prevention of LV Thrombus Formation After Anterior Wall Myocardial Infarction: A 60 Patient Pilot Study
Lead sponsor Corewell Health East, Other
Collaborators Rhone-Poulenc Rorer Industry
Status Completed
Study type Interventional
Conditions Coronary Artery Disease, Acute Myocardial Infarction
Intervention type Drug
Interventions Enoxaparin
Enrollment 60
Start date Mar 1, 2000
Completion Apr 1, 2004
First posted May 3, 2006
Last update posted May 3, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies